EE04235B1 - Combination of active substances, namely tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of the Alzheimer's disease type - Google Patents
Combination of active substances, namely tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of the Alzheimer's disease typeInfo
- Publication number
- EE04235B1 EE04235B1 EEP200000290A EEP200000290A EE04235B1 EE 04235 B1 EE04235 B1 EE 04235B1 EE P200000290 A EEP200000290 A EE P200000290A EE P200000290 A EEP200000290 A EE P200000290A EE 04235 B1 EE04235 B1 EE 04235B1
- Authority
- EE
- Estonia
- Prior art keywords
- tetrahydropyridines
- alzheimer
- namely
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714322A FR2771007B1 (en) | 1997-11-14 | 1997-11-14 | COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE |
FR9714324A FR2771006B1 (en) | 1997-11-14 | 1997-11-14 | COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE |
PCT/FR1998/002384 WO1999025363A1 (en) | 1997-11-14 | 1998-11-09 | Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200000290A EE200000290A (en) | 2001-06-15 |
EE04235B1 true EE04235B1 (en) | 2004-02-16 |
Family
ID=26233932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200000290A EE04235B1 (en) | 1997-11-14 | 1998-11-09 | Combination of active substances, namely tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of the Alzheimer's disease type |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1030671A1 (en) |
JP (1) | JP2001523642A (en) |
KR (1) | KR100599350B1 (en) |
CN (1) | CN1243540C (en) |
AU (1) | AU743228B2 (en) |
BG (1) | BG64819B1 (en) |
BR (1) | BR9814035A (en) |
CA (1) | CA2309966A1 (en) |
CO (1) | CO4980891A1 (en) |
DZ (1) | DZ2649A1 (en) |
EA (1) | EA003255B1 (en) |
EE (1) | EE04235B1 (en) |
HU (1) | HUP0100098A3 (en) |
ID (1) | ID24933A (en) |
IL (2) | IL136122A0 (en) |
IS (1) | IS5482A (en) |
MY (1) | MY120461A (en) |
NO (1) | NO20002450L (en) |
NZ (1) | NZ504420A (en) |
OA (1) | OA11464A (en) |
PL (1) | PL194597B1 (en) |
SA (1) | SA98190747B1 (en) |
SK (1) | SK286040B6 (en) |
TR (1) | TR200001262T2 (en) |
TW (1) | TW585766B (en) |
UY (1) | UY25247A1 (en) |
WO (1) | WO1999025363A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL217394B1 (en) | 2002-06-14 | 2014-07-31 | Toyama Chemical Co Ltd | Medicinal compositions improving brain function and method for improving brain function |
US20060160079A1 (en) * | 2002-08-07 | 2006-07-20 | Lane Roger M | Methods for the treatment of dementia based on apo e genotype |
CN1520818A (en) * | 2003-02-09 | 2004-08-18 | 山东绿叶天然药物研究开发有限公司 | Cholinesterase inhibitor pharmaceutical composition for senile dementia |
NZ555693A (en) | 2004-12-27 | 2010-10-29 | Eisai R&D Man Co Ltd | Matrix type sustained-release preparation containing donepezil |
WO2015116923A1 (en) | 2014-01-31 | 2015-08-06 | Cognition Therapeutics, Inc. | Isoindoline compositions and methods for treating neurodegenerative disease |
US11214540B2 (en) | 2017-05-15 | 2022-01-04 | Cognition Therapeutics, Inc. | Compositions for treating neurodegenerative diseases |
KR102224918B1 (en) | 2018-03-20 | 2021-03-09 | (주)인벤티지랩 | Pharmaceutiical composition comprising memantine and donepezil for preventing or treating cognitive impairment-related disease and preparation method thereof |
WO2019182319A1 (en) * | 2018-03-20 | 2019-09-26 | (주)인벤티지랩 | Method for preparing pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, and pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, prepared by preparation method |
CN109265391B (en) * | 2018-11-13 | 2021-11-19 | 枣庄学院 | Biphenyl polysubstituted 1,2,5, 6-tetrahydropyridine compound and synthetic method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2662355B1 (en) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS. |
US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
PT813416E (en) * | 1995-03-06 | 2005-10-31 | Interneuron Pharma | REDUCING VOLUME OF FUNGUS USING CITICOLIN |
FR2736053B1 (en) * | 1995-06-28 | 1997-09-19 | Sanofi Sa | NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES |
-
1998
- 1998-10-26 CO CO98062479A patent/CO4980891A1/en unknown
- 1998-10-28 TW TW087117874A patent/TW585766B/en not_active IP Right Cessation
- 1998-11-09 SK SK711-2000A patent/SK286040B6/en unknown
- 1998-11-09 CN CNB988130947A patent/CN1243540C/en not_active Expired - Fee Related
- 1998-11-09 EA EA200000412A patent/EA003255B1/en not_active IP Right Cessation
- 1998-11-09 HU HU0100098A patent/HUP0100098A3/en unknown
- 1998-11-09 JP JP2000520796A patent/JP2001523642A/en not_active Withdrawn
- 1998-11-09 WO PCT/FR1998/002384 patent/WO1999025363A1/en not_active Application Discontinuation
- 1998-11-09 BR BR9814035-3A patent/BR9814035A/en not_active Application Discontinuation
- 1998-11-09 KR KR1020007005231A patent/KR100599350B1/en not_active IP Right Cessation
- 1998-11-09 IL IL13612298A patent/IL136122A0/en not_active IP Right Cessation
- 1998-11-09 EP EP98954538A patent/EP1030671A1/en not_active Withdrawn
- 1998-11-09 TR TR2000/01262T patent/TR200001262T2/en unknown
- 1998-11-09 AU AU11609/99A patent/AU743228B2/en not_active Ceased
- 1998-11-09 PL PL98340500A patent/PL194597B1/en not_active IP Right Cessation
- 1998-11-09 EE EEP200000290A patent/EE04235B1/en not_active IP Right Cessation
- 1998-11-09 CA CA002309966A patent/CA2309966A1/en not_active Abandoned
- 1998-11-09 NZ NZ504420A patent/NZ504420A/en unknown
- 1998-11-09 ID IDW20000860A patent/ID24933A/en unknown
- 1998-11-11 DZ DZ980259A patent/DZ2649A1/en active
- 1998-11-12 UY UY25247A patent/UY25247A1/en not_active IP Right Cessation
- 1998-11-14 SA SA98190747A patent/SA98190747B1/en unknown
- 1998-11-14 MY MYPI98005180A patent/MY120461A/en unknown
-
2000
- 2000-05-09 IS IS5482A patent/IS5482A/en unknown
- 2000-05-11 BG BG104428A patent/BG64819B1/en unknown
- 2000-05-11 NO NO20002450A patent/NO20002450L/en unknown
- 2000-05-12 OA OA1200000141A patent/OA11464A/en unknown
- 2000-05-14 IL IL136122A patent/IL136122A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE253361T1 (en) | AGENTS FOR THE CONTROLLED RELEASE OF PAROXETINE | |
DE60023128D1 (en) | PYRAZOLECARBOXAMIDE FOR THE TREATMENT OF FATIBILITY AND OTHER DISEASES | |
DE69806801T2 (en) | GALENIC PREPARATION FOR THE PREVENTION AND TREATMENT OF HEPATOCARCINOMAS | |
DE60022867D1 (en) | 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine Derivatives for the treatment of CNS disorders | |
NO990433D0 (en) | New compounds and compositions for the treatment of diseases associated with tryptase activity | |
HUP9900927A3 (en) | Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases | |
AU1509999A (en) | Herbal drug composition for the prevention and treatment of dementia | |
NO20001869D0 (en) | Procedures for the treatment of Alzheimer's disease | |
EE200000290A (en) | Combination of active substances, namely tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of the Alzheimer's disease type | |
AU3364499A (en) | Method for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders | |
ATE234617T1 (en) | USE OF THE SAREDUTANT AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE TREATMENT OF SEVERE DEPRESSION | |
PT888114E (en) | USING (+) - ALPHA- (2,3-DIMETOXYPHENYL) -1- [2- (4-FLUOROPHENYL) ETHYL] -4-PIPERIDINOMETHANOL IN THE TREATMENT OF DEPRESSIVE DISEASES AND BIPOLAR DISEASES | |
ATE346840T1 (en) | AMINOALKYLPHENOL DERIVATIVES FOR THE TREATMENT OF DEPRESSION AND MEMORY DISORDER | |
GR3033316T3 (en) | Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders | |
NO981499D0 (en) | Process for the preparation of titanium dioxide | |
NO20003145D0 (en) | Process for the preparation of paroxetine hydrochloride | |
NO20014026D0 (en) | Antispasmodic derivatives for the treatment of significant tremor | |
KR100248098B1 (en) | Pharmaceutical composition for the treatment of dementia | |
FR2718027B1 (en) | Product intended for the treatment and prevention of alopecia. | |
HUP0202145A3 (en) | The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders | |
ZA989955B (en) | Combination of active ingredients for the treatment of senile dementia of the alzheimer type | |
ZA974390B (en) | Carboxamide derivatives of pyrrolidine piperidine and hexahydroazepine for the treatment of thrombosis disorders. | |
FI970269A0 (en) | Mixtures of 1,3-diol-based esters, process for the preparation of 1,3-diol-based esters and use of esters | |
HUP9902445A3 (en) | Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine and pharmaceutical compositions containing them for the treatment of thrombosis disorders | |
ZA969484B (en) | Novel substituted 4-(1H-benzimidazol-2-yl-amino)- piperidines useful for the treatment of allergic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HD1A | Correction of address | ||
HC1A | Change of owner name | ||
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20081109 |